About Schizophyllum commune
A widespread mushroom that produces the beta-glucan schizophyllan (sizofiran), historically studied as an injectable immunomodulant in oncology. As an oral supplement ingredient it has essentially no controlled human evidence; usually a component of mushroom blends.
What Schizophyllum commune supports
- Source of the beta-glucan schizophyllan; no meaningful oral supplement evidence
How much Schizophyllum commune to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
100–2000
mg
No established oral supplement dose; nominal range. Its beta-glucan schizophyllan has been studied as an injectable immunomodulator, not as an oral supplement.
Clinical evidence
Limited clinical evidence. Injectable beta-glucan history; no oral-supplement RCTs.